Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events

Angiogenesis

Volumn 8, Issue 4, 2006, Pages 315-326

  Werdich, Xiang Q ^a   Penn, John S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fyn; RNA interference; Src; Vascular endothelial growth factor; Yes

Indexed keywords

DNA FRAGMENT; PROTEIN; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; RETINA BLOOD VESSEL; RNA INTERFERENCE; VASCULAR ENDOTHELIUM;

CELL MOVEMENT; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICROVESSELS; MITOGENS; MITOSIS; PROTO-ONCOGENE PROTEINS C-FYN; PROTO-ONCOGENE PROTEINS C-YES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RETINAL VESSELS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33644595058     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-005-9021-x     Document Type: Article

References (60)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
2. Griffioen AW, Molema G. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52: 237-68.
3. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 1997; 151: 13-23.
4. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol 2000; 184: 301-10.
5. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
6. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-8.
7. Leung DW, Cachianes G, Kuang WJ et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
8. Senger DR, Galli SJ, Dvorak AM et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
9. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
10. Waltenberger J, Claesson-Welsh L, Siegbahn A et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 269: 26988-95.
11. Alon T, Hemo I, Itin A et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1: 1024-8.
12. Gerber HP, McMurtrey A, Kowalski J et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-KDR activation. J Biol Chem 1998; 273: 30336-43.
13. De VC, Escobedo JA, Ueno H et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-91.
14. Terman BI, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579-86.
15. Millauer B, Wizigmann-Voos S, Schnurch H et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-46.
16. Peters KG, de Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993; 90: 8915-9.
17. Eliceiri BP, Paul R, Schwartzberg PL et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999; 4: 915-24.
18. He H, Venema VJ, Gu X et al. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 1999; 274: 25130-5.
19. Abu-Ghazaleh R, Kabir J, Jia H et al. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J 2001; 360: 255-64.
20. Zachary I. VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem Soc Trans 2003; 31: 1171-7.
21. Eliceiri BP, Puente XS, Hood JD et al. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 2002; 157: 149-60.
22. Tsuda S, Ohtsuru A, Yamashita S et al. Role of c-Fyn in FGF-2-mediated tube-like structure formation by murine brain capillary endothelial cells. Biochem Biophys Res Commun 2002; 290: 1354-60.
23. Kilarski WW, Jura N, Gerwins P. Inactivation of Src family kinases inhibits angiogenesis in vivo: Implications for a mechanism involving organization of the actin cytoskeleton. Exp Cell Res 2003; 291: 70-82.
24. Kumar P, Amin MA, Harlow LA et al. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 2003; 101: 3960-8.
25. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13: 513-609.
26. Bull HA, Brickell PM, Dowd PM. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett 1994; 351: 41-4.
27. Kiefer F, Anhauser I, Soriano P et al. Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases. Curr Biol 1994; 4: 100-9.
28. Lowell CA, Soriano P. Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories. Genes Dev 1996; 10: 1845-57.
29. Paul R, Zhang ZG, Eliceiri BP et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001; 7: 222-7.
30. Lutty GA, McLeod DS, Merges C et al. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996; 114: 971-7.
31. Vinores SA, Youssri AI, Luna JD et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997; 12: 99-109.
32. Elbashir SM, Harborth J, Lendeckel W et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8.
33. Tijsterman M, Ketting RF, Plasterk RH. The genetics of RNA silencing. Annu Rev Genet 2002; 36: 489-519.
34. Elbashir SM, Harborth J, Weber K et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002; 26: 199-213.
35. McManus MT, Haines BB, Dillon CP et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J Immunol 2002; 169: 5754-60.
36. Holen T, Amarzguioui M, Wiiger MT et al. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 2002; 30: 1757-66.
37. Parrish S, Fleenor J, Xu S et al. Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference. Mol Cell 2000; 6: 1077-87.
38. Tuschl T, Elbashir SM, Harborth J et al. The siRNA user guide. http://www rockefeller edu/labheads/tuschl/sirna html 2004.
39. Ding Q, Stewart J Jr, Olman MA et al. The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged. J Biol Chem 2003; 278: 39882-91.
40. Rodriguez-Nieto S, Gonzalez-Iriarte M, Carmona R et al. Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J 2001; 01-427fje.
41. Guo D, Jia Q, Song HY et al. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem 1995; 270: 6729-33.
42. Xia P, Aiello LP, Ishii H et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996; 98: 2018-26.
43. Resh MD. Myristylation and palmitylation of Src family members: The fats of the matter. Cell 1994; 76: 411-3.
44. Robbins SM, Quintrell NA, Bishop JM. Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Mol Cell Biol 1995; 15: 3507-15.
45. Kaplan KB, Swedlow JR, Varmus HE et al. Association of p60c-src with endosomal membranes in mammalian fibroblasts. J Cell Biol 1992; 118: 321-33.
46. Magee AI, Gutierrez L, McKay IA et al. Dynamic fatty acylation of p21N-ras. EMBO J 1987; 6: 3353-7.
47. Walker F, deBlaquiere J, Burgess AW. Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. J Biol Chem 1993; 268: 19552-8.
48. Majno G, Joris I. Apoptosis, oncosis, and necrosis An overview of cell death. Am J Pathol 1995; 146: 3-15.
49. Fadok VA, Voelker DR, Campbell PA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-16.
50. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 1999; 47: 1101-10.
51. Rousseau S, Houle F, Kotanides H et al. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 2000; 275: 10661-72.
52. Gille H, Kowalski J, Li B et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 2001; 276: 3222-30.
53. Barleon B, Sozzani S, Zhou D et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336-43.
54. Clauss M, Weich H, Breier G et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271: 17629-34.
55. Kanno S, Oda N, Abe M et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 2000; 19: 2138-46.
56. Gille H, Kowalski J, Yu L et al. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. EMBO J 2000; 19: 4064-73.
57. Chou MT, Wang J, Fujita DJ. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 2002; 3: 32.
58. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737-47.
59. Bridge AJ, Pebernard S, Ducraux A et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263-4.
60. Sledz CA, Holko M, de Veer MJ et al. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003: 5: 834-9.